key: cord-0847487-49toz7s2
authors: Bardazzi, Federico; Guglielmo, Alba; Abbenante, Diego; Sacchelli, Lidia; Sechi, Andrea; Starace, Michela Valeria Rita
title: New insights into alopecia areata during COVID‐19 pandemic: When infection or vaccination could play a role
date: 2022-03-14
journal: J Cosmet Dermatol
DOI: 10.1111/jocd.14864
sha: 5afd71f425bd5b267611fb1fb19e0bc884a444f7
doc_id: 847487
cord_uid: 49toz7s2

-

To the editor, Alopecia areata (AA) is an autoimmune disease characterized by non-scarring hair loss due to inflammatory responses that target the hair follicles. Infectious agents, including viruses, have been associated with the onset or progression of AA. The link with vaccines is more controversial, despite some cases have been reported. 1 We present six cases of AA, 3 after SARS-CoV-2 infection, and 3 beginning after COVID-19 vaccination (Table S1) .

We herein report the case of three patients (2 female patients and 1 male patient) aged 28-56 years who presented with patchy AA on the scalp after a moderate SARS-CoV-2 infection, beginning after a time gap of 2-3 weeks (Figure 1 ). In all the cases, COVID-19 was confirmed by PCR test. None of them required hospitalization, and eventually healed within 3 weeks after symptoms onset. Only one of them had a previous episode of a single alopecic patch of the scalp 4 years before. All patients applied Trichoscopy of all cases showed features of disease activity, including black dots, broken hairs, and exclamation mark hairs.

Median SALT scores for disease activity were higher in the postvaccination group than in the post-infectious one (56 ± 38.9 vs.

10.6 ± 7).

Written informed consent was obtained by all patients.

During the COVID-19 pandemic, an increased incidence of AA has been observed, but only a few cases were associated with a 

Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure

Short-term stress-related increasing cases of alopecia areata during the COVID-19 pandemic

New onset of alopecia areata in a patient with SARS-COV-2 infection: Possible pathogenetic correlations?

Recurrence of alopecia areata after COVID-19 vaccination: A report of three cases in Italy

Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients

Alopecia areata after ChAdOx1 nCoV-19 vaccine (Oxford/AstraZeneca): a potential triggering factor?